Global and United States Needle-free Injection Systems Market Report & Forecast 2022-2028
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Market Analysis and Insights: Global and United States Needle-free Injection Systems Market
This report focuses on global and United States Needle-free Injection Systems market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Needle-free Injection Systems market size is estimated to be worth US$ 211.1 million in 2022 and is forecast to a readjusted size of US$ 284.5 million by 2028 with a CAGR of 5.1% during the review period. Fully considering the economic change by this health crisis, by Power, Reusable Injector accounting for % of the Needle-free Injection Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Vaccine Delivery was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
Global Needle-free Injection Systems Scope and Market Size
Needle-free Injection Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Needle-free Injection Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Needle-free Injection Systems market size by players, by Power and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Power
Reusable Injector
Single-use Injector
Segment by Application
Vaccine Delivery
Insulin Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Market Analysis and Insights: Global and United States Needle-free Injection Systems Market
This report focuses on global and United States Needle-free Injection Systems market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Needle-free Injection Systems market size is estimated to be worth US$ 211.1 million in 2022 and is forecast to a readjusted size of US$ 284.5 million by 2028 with a CAGR of 5.1% during the review period. Fully considering the economic change by this health crisis, by Power, Reusable Injector accounting for % of the Needle-free Injection Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Vaccine Delivery was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
Global Needle-free Injection Systems Scope and Market Size
Needle-free Injection Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Needle-free Injection Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Needle-free Injection Systems market size by players, by Power and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Power
Reusable Injector
Single-use Injector
Segment by Application
Vaccine Delivery
Insulin Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
